Protecting Two Generations: Dr. Moraba Leads RSV Vaccine Trial for Mothers with HIV and Their Infants
Respiratory Syncytial Virus (RSV) is a leading cause of severe respiratory illness in infants. Pregnant women living with HIV and
The Foundation of Discovery: Dr. Moraba’s Directorship in Clinical Trial Operations
Beyond any single study, Dr. Sehulong Robert Moraba’s most significant accomplishment may be his foundational role as Clinical Trials Director and
The Foundation of Discovery: Dr. Moraba’s Directorship in Clinical Trial Operations Read Post »
A Revolution in HIV Prevention: Dr. Moraba Leads Phase 3 Trial of Long-Acting Lenacapavir
Adherence to daily pills is a major challenge for HIV prevention. Dr. Sehulong Robert Moraba was at the forefront of
Exploring a Novel HIV Vaccine Strategy: Dr. Moraba’s Role in the VIR-1388 Trial
While antiretroviral therapy has transformed HIV into a manageable condition, the search for a preventive vaccine continues. Dr. Sehulong Robert
Exploring a Novel HIV Vaccine Strategy: Dr. Moraba’s Role in the VIR-1388 Trial Read Post »
Evaluating a Next-Generation TB Vaccine: Dr. Moraba in MTBVAC Phase 2a Trial
Building on the fight against TB, Dr. Sehulong Robert Moraba also contributed to the development of MTBVAC, a live-attenuated vaccine derived
Evaluating a Next-Generation TB Vaccine: Dr. Moraba in MTBVAC Phase 2a Trial Read Post »
Shortening and Simplifying TB Treatment: Dr. Moraba’s Work on the NC-009 Trial
The standard treatment for drug-sensitive TB is lengthy and complex. Dr. Sehulong Robert Moraba participated in research aimed at changing
Shortening and Simplifying TB Treatment: Dr. Moraba’s Work on the NC-009 Trial Read Post »
The PEARL Trial: Dr. Moraba Helps Evaluate an RSV Vaccine for the Youngest Children
The burden of RSV is highest in the very young. Dr. Sehulong Robert Moraba participated in a major international effort
The PEARL Trial: Dr. Moraba Helps Evaluate an RSV Vaccine for the Youngest Children Read Post »
Protecting the Most Vulnerable: Dr. Moraba in Moderna’s Maternal RSV Vaccine Trial
Following his work on the mRNA flu vaccine, Dr. Sehulong Robert Moraba also contributed to Moderna’s pipeline for maternal health.
Protecting the Most Vulnerable: Dr. Moraba in Moderna’s Maternal RSV Vaccine Trial Read Post »
Beyond the Pandemic: Dr. Moraba in Early Trial for Next-Gen COVID-19 Vaccines
As the COVID-19 pandemic evolved, so did the search for next-generation vaccines. Dr. Sehulong Robert Moraba contributed to this effort
Beyond the Pandemic: Dr. Moraba in Early Trial for Next-Gen COVID-19 Vaccines Read Post »
Expanding HIV Prevention Options for Young Women: Dr. Moraba in F/TAF PrEP Trial
Adolescent girls and young women in sub-Saharan Africa remain disproportionately affected by HIV. Dr. Sehulong Robert Moraba worked to expand
Expanding HIV Prevention Options for Young Women: Dr. Moraba in F/TAF PrEP Trial Read Post »
Building Foundations for Future Breakthroughs: Dr. Moraba in TB Vaccine Preparedness Study
Before a large efficacy trial can launch, critical groundwork must be laid. Dr. Sehulong Robert Moraba served as a Sub-Investigator for a
Fighting Drug-Resistant STIs: Dr. Moraba in Trial for First New Gonorrhoea Drug in Decades
With rising antibiotic resistance, gonorrhoea is becoming harder to treat. Dr. Sehulong Robert Moraba contributed to the fight against this
The Future of Flu Shots: Dr. Moraba as Principal Investigator for Moderna’s mRNA Vaccine Trial
The success of mRNA technology during the COVID-19 pandemic opened new avenues for other vaccines. Dr. Sehulong Robert Moraba took
A Historic Step Forward: Dr. Moraba Contributes to Phase 3 Trial of Promising TB Vaccine
Tuberculosis remains one of the world’s deadliest infectious diseases. The M72/AS01E vaccine candidate has emerged as one of the most promising new
A Historic Step Forward: Dr. Moraba Contributes to Phase 3 Trial of Promising TB Vaccine Read Post »
